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Abstract 
We investigate the effect of initial provider (primary care physician, psychiatrist, or non-
physician mental health specialist) on the adequacy of subsequent treatment for persons with 
depression. Our data are from MarketScan®, a medical and pharmacy insurance claims database, 
which we use to estimate models of the likelihood of treatment for depression and the likelihood 
that any treatment received is adequate. Patients initially seeing psychiatrists are most likely to 
receive adequate treatment. Provider type has a statistically and medically significant effect on 
whether any treatment occurs but a smaller effect on treatment adequacy among treated patients. 
The results show the importance of provider type in treatment patterns, but the effects on patient 
outcomes are yet to be determined definitively. 
 
Introduction 
 Depression is a widespread illness in the United States and elsewhere, and although cost-
effective treatments exist, many persons remain untreated or inappropriately treated (Wells et al. 
1996). The popular press has noted the apparent paradox that mental health treatment has 
significant long-term benefits to society and yet is the subject of stigma, which permeates a cycle 
of under-treatment (Cloud 1999). Although many mentally ill persons who are untreated are 
outside the social safety net, even among persons covered by health insurance plans the 
treatment of depression is frequently inadequate and not cost-effective (Wells et al. 1996). We 
present evidence on how the course of treatment for persons with depression varies by type of 
initial care provider. 
 To treat depression cost-effectively, patients would ideally be matched with therapies 
most cost-effective for them individually. Mental health systems often perform poorly at 
matching patients with their ideal providers, creating access problems for patients who could be 
helped and creating waste from patients who consume resources that are of little therapeutic 
benefit (McGuire 1995). To treat depressed enrollees more cost-effectively, health plans need to 
study the effects of directing patients into particular pathways of care. An important component 
of directing a patient’s course of treatment is the provider who first diagnoses the depression. A 
key collateral issue is then how the course of treatment compares among the various types of 
providers so as to understand how health insurance systems, both directly through their benefit 
structures and indirectly through care decisions of mental health providers, influence the 
adequacy of care for depression. 
 The role of provider specialty is particularly important in treating mental conditions such 
as depression, where the range of treatment options available to a patient may depend heavily on 
the training of the provider treating the patient. General medical practitioners, psychiatrists, 
psychologists, and psychiatric social workers or other non-physician mental health specialists 
  
can treat patients suffering from depression, and many patients are treated by more than one type 
of professional. Because each provider type has unique training and expertise, the course of 
treatment is likely to vary among provider types. The consequences of provider type differences 
for patients with mental disorders are still not clearly established, and our contribution is to 
investigate how provider type affects treatment adequacy among patients diagnosed with 
depression. 
We find that provider type is significantly related to the adequacy of treatment of a 
depressed person. A depressed person initially diagnosed by a general medical practitioner 
psychiatrist is about seven times more likely to go untreated than a similar depressed person 
initially diagnosed by a psychiatrist. No treatment is up to 15 times more likely to occur if the 
depressed person is diagnosed by a non-physician provider than if the person is diagnosed by a 
psychiatrist. Although type of initial provider affects the dimension of treatment adequacy via 
the existence of any depression treatment, we find that initial provider type is much less relevant 
to whether the amount of the treatment selected is considered adequate. Any connection between 
initial provider and eventual patient outcome concerning depression largely occurs through 
whether treatment is initiated at all rather than through intensity of treatment once initiated. 
Background Literature 
 The role of the health care provider has been of much research concern because of its 
potential importance in determining the course of treatment of certain ailments. Specialty of the 
health care provider has been shown to have wide-ranging medically and economically 
significant effects on treatment intensity, costs, and outcomes. 
Brief Review of Provider Specialty Impact 
The general relationship between provider specialty and pattern of care and costs is still 
unclear. Interconnections seem to depend crucially on the particular diagnosis under study. For 
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example, outcomes of persons suffering a myocardial infarction vary according to whether the 
patient was admitted to the hospital by a generalist or a specialist (Jollis et al. 1996). In contrast, 
among persons with symptoms of knee osteoarthritis, physician specialty and specific 
management practices seem not to account for variations in patient outcomes (Mazzuca et al. 
1997). Research on asthma patients suggests that treatment intensity may be greater for persons 
treated by specialists (Engel et al. 1989). Although treatment costs are necessarily higher for 
asthma patients treated by specialists, the greater treatment intensity does not clearly result in 
better outcomes (Freund et al. 1988). As a final overview example, we note that costs of treating 
episodes of various musculoskeletal conditions seem to be lower for persons referred to a 
specialist earlier in the course of treatment (Nyman et al. 1998). The role of provider specialty in 
medical and economic outcomes seems to be context specific. 
Brief Review of Provider Specialty in Mental Health Care 
 Similar to results we have described above, the connections among treatment modes, 
provider types, costs, and outcomes for users of mental health services are not generalizeable. 
Still, some results are worth noting briefly. Compared to usual depression care by general 
medical practitioners, patients receiving guideline-based pharmacotherapy and psychotherapy 
interventions (via pharmacotherapy provided by trained primary care physicians using scripted 
interpersonal psychotherapy) had superior outcomes at modestly higher cost (Lave et al. 1998). 
Because depression treatment studies suggest there are important style differences across the 
various types of mental health care providers, some researchers have concluded that, where 
mental health care is concerned, policies should channel patients away from primary care 
providers because general medical practitioners too often administer superficial treatment 
(Mechanic 1990; Wells et al. 1996). Some research also suggests that mental health care initiated 
by general medical providers is as expensive as treatment initiated by psychiatrists and more 
expensive than treatment initiated by non-medical providers (Holmes and Deb 1998). 
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 Looking within treatment for mental illness, research on differences in counseling styles 
for depression across the provider specialties of psychiatry, psychology, and general medicine 
have found that general practitioners counsel less than psychiatrists and psychologists. 
Furthermore, compared with other mental health specialists, master’s level clinicians reveal 
lower skill at counseling for psychosocial problems (Meredith et al. 1996). Although 
pharmacotherapy seems to be more important than other treatment factors concerning the dual 
outcomes of cost of care and pharmacotherapy completion, targeted concurrent psychotherapy 
can be cost-effective (Dobrez et al. 2000). 
 Differences in the type of care delivered by one provider type compared to another are, in 
part, determined by variation in education, training, and other provider factors. Care differences 
can also be partly determined by the preferences of patients, who choose providers based on the 
types of care they offer. Based on the limited existing literature, it appears that patients’ 
preferences are more likely to affect the decision to seek any care rather than the type of care 
(Frank and Kamlet 1989; Ettner and Herman 1997; Fortney, Rost, and Zhang 1998; Swindle et 
al. 2000). So, patient demographic factors, such as age, gender, health, and mental health status 
have not been found to predict well the choice of particular provider specialties. Only geographic 
proximity and insurance have been shown to have much influence on patients’ use of 
psychiatrists and mental health specialists (Fortney, Rost, and Zhang 1998; Ettner and Herman 
1997).1  
Our contribution is to add to the understanding of importance of provider type in caring 
for depression. We answer two questions concerning the extensive and intensive dimensions of 
anti-depression treatment: How does initial provider type matter in whether treatment occurs at 
all? If treatment does occur, are there important differences in treatment adequacy across 
provider types? 
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Conceptual Framework 
 Our starting point is that medical treatment is a joint decision of the patient and a health 
care provider concerning both the extensive and intensive margins of treatment (Pohlmeier and 
Ulrich 1995). We adopt a two-stage decision making view of depression treatment in which the 
first decision is whether treatment begins and the second decision, conditional on the initiation of 
treatment, is the intensity (adequacy) of treatment.2 More specifically, if the latent index 1y
∗ , 
which represents the difference between the depressed patient’s (utility) benefits and costs of 
treatment, is positive, then treatment occurs. Similarly, if the latent index , which represents 
the difference between the depressed patient’s (utility) benefits and costs of intensive (adequate) 
treatment conditional on treatment beginning, is positive, then treatment is adequate. Expressed 
algebraically, the conceptual model that we estimate describes the joint likelihood that treatment 
occurs and is adequate 
2y
∗
 y1 = Prob (treatment) = f1(X1) and              (1) 
 y2 = Prob (adequate treatment | treatment) = f2(X2 | ),           (2) 1 0y
∗ >
where X1 are observed exogenous variables affecting the likelihood of treatment and X2 are 
observed exogenous variables affecting treatment intensity for patients treated, which will have 
elements common to X1. 
 Because the conceptual model of depression treatment in Equations (1) and (2) most 
logically represents treatment and treatment adequacy as (joint) probabilistic outcomes, it must 
be made stochastic by allowing the underlying net utility indexes, jy
∗ , to have unmeasured 
components in addition to the observed patient and health care provider attributes in Xj ( j = 1, 2). 
The empirical representation that we will estimate admits stochastic parts of Equations (1) and 
(2) that are correlated, which represents a latent common factor, so that the model is in the spirit 
of the well-known generalized multi-equation regression framework known as seemingly 
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unrelated regressions or SUR (Greene 2003). Our ultimate research objective is to produce 
estimates of the differential or so-called marginal effect (ME) on each of the two outcomes of 
interest in anti-depression treatment from having a psychiatrist versus another type of initial 
provider. 
Empirical Framework 
We undertake a multivariate empirical model focusing on two dimensions of treatment 
adequacy: whether treatment occurs at all and whether any treatment occurring is intensive 
enough to be considered adequate. The independent variable of most interest in our study is 
qualitative – provider type. We first determine in a single equation context whether persons 
diagnosed with depression are treated (with psychotherapy, pharmacotherapy, or both) versus 
remaining untreated after diagnosis. Using a multiple equation model considering jointly the 
extensive and intensive dimensions of anti-depression treatment, we then examine the influence 
of provider type on whether treatment is intensive enough to be considered adequate among 
patients treated. Our multi-equation models adjust for nonrandom assignment of treatment and 
address whether our conclusions are robust to the possibility that patients select the particular 
type of initial provider based on latent (to the researcher) factors underlying likely treatment and 
its adequacy. 
The Bivariate Probit Model 
Let y1 be the binary variable indicating whether treatment occurs and y2 be the binary 
variable indicating whether any treatment occurring is deemed medically adequate. The bivariate 
probit model we use for our core results estimates y1 = f1(X1) + e1 and y2 = f2(X2) + e2 where Xj is 
the matrix of independent variables (j = 1, 2). The error terms (ej’s) in the bivariate probit are 
taken as following a standard bivariate normal cdf where the ej’s each have mean zero and unit 
variance and a covariance of ρ. The particular variant of the bivariate probit we use for our core 
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results takes account of the non-random composition of the data for the second stage of anti-
depression treatment because the model incorporates statistically in the likelihood function that it 
is only when there is treatment (y1 = 1) are there data on adequacy of treatment (y2 and X2) 
(Greene 2003).3 
Data 
 Our sample is from the Marketscan® database, which contains standardized medical and 
prescription claims of enrollees in private employer-provided health plans across the United 
States, representing about six percent of corporate health care insurance expenditures. Because 
sample members are in similar health insurance situations overall, insurance generosity and 
particular mental health coverage differences are implicitly held constant in our empirical results, 
which also means that we do not examine the issue of how health insurance parameters influence 
initial provider and subsequent treatment adequacy. We use insurance claims data from 1990–
1994 for patients diagnosed with depression, including outpatient procedure codes and 
prescription claims. To be included in our sample, patients must have claims information for the 
entire six months before diagnosis and for the entire 12 months after diagnosis. Because 
depression in children and in geriatric populations may require special consideration, we limit 
our sample to patients ages 18 to 65. As noted in the summary statistics in Table 1, our study 
sample size is 5,562 persons; 74 percent are women, and the mean age is 41.  
 Patients’ diagnostic categories reflect the first listed depressive disorder identified on the 
index claim during the episode. As seen in Table 1, approximately 11 percent of patients were 
diagnosed with single episode major depressive disorder, 9 percent with recurrent major 
depressive disorder, 67 percent with dysthymic disorder, and 13 percent with depression not 
otherwise specified.4 About 22 percent of sample patients had their initial diagnosis from a 
general medical provider, 44 percent from a psychiatrist, 6 percent from a psychologist, and 34 
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percent by a non-physician mental health therapist, which we subsequently refer to as a master’s 
level clinician. 
 Our data represent episodes of care for persons diagnosed with depression. Each episode 
is indexed by the initial occurrence of a claim with a diagnosis of a depressive disorder, 
including single and recurrent episode major depression, dysthymia, and depression not 
otherwise specified. We call the first six-month period of each episode the pre-diagnosis period. 
Although symptoms of depression may exist, there is no record of either diagnosis or treatment 
for depression during the pre-diagnosis period. The 12 months following the index claim 
comprise the follow-up period, during which we use the claims data to characterize treatment as 
falling into one of four categories: (1) medication only, (2) psychotherapy only, (3) combination 
therapy, or (4) no treatment. As noted in Table 1, about 10 percent of patients had treatment 
using antidepressant medication only, 35 percent had treatment using psychotherapy only, about 
20 percent had treatment with both medication and psychotherapy, and 35 percent were not 
treated at all within the health plan system after diagnosis. 
 It is important to mention, and then argue against, a possible important omitted variable 
in our data and associated omitted variable bias in our empirical results. In a general setting, 
provider type may be determined by health insurance parameters, and the effects of provider type 
on depression treatment could greatly reflect insurance differences across patients, rather than 
any independent effect of provider type. For example, insufficient insurance coverage could 
encourage people to seek care initially from a psychologist and then not to pursue subsequent 
treatment on economic grounds. There is some support in the literature for the perspective that 
care is hard to afford based on studies of persons seeking mental health treatment (Fortney, Rost, 
and Zhang 1998; Holmes and Deb 1998). Many other studies that include a larger, community 
perspective find that there are many forces affecting provider choice other than insurance, and 
that non-insurance factors are also probably more important than insurance (Swindle et al. 2000). 
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Because most Americans also do not know what their mental health benefit is, insurance seems 
unlikely to be a crucial factor in care seeking behavior initially (Mickus, Colenda, and Hogan 
2000). Insurance generosity, as metered by expected out-of-pocket payments, also does not 
predict use of certain providers over others, such as psychiatrists versus general medical 
practitioners (Holmes and Deb 1998). So, the most important point for our research objective is 
that the marginal influence of provider type should not be confounded with that of insurance 
generosity in our particular data set because the entire cohort we study has similar employer-
provided health insurance coverage. 
A limitation of our data is that the provider effects we estimate have been cleansed of any 
confounding effects of insurance differences across patients; we control for insurance coverage 
indirectly as our data are for persons with similar coverage. Stratification by similar insurance 
also means that our results are moot concerning how insurance generosity might influence, or 
even dominate, the provider effects on adequacy of depression care. 
In studying the link between provider type and adequacy of treatment, one might also 
want to consider more deeply than we can with our data the issue of whether there are important 
latent differences across people designated as depressed by different providers in the first place. 
Does a diagnosis of a depressive disorder on a claim from a counselor mean the same thing as on 
a claim from a psychiatrist? 
 We also take note of an unusually high percentage of persons with dysthymic disorder in 
our data. Prior studies using MarketScan® have noted that about 30 percent of claims list 
dysthymia as the primary depression diagnosis, which is about half the incidence of a dysthymic 
disorder in our sample. To investigate the impact of the high incidence of dysthymia, we 
stratified the sample into persons who received an antidepressant, which is a cohort similar to 
data in other studies (Hylan et al, 1999) and persons who did not receive an antidepressant. Rates 
of dysthymia approached more than 75 percent in the group of patients who did not receive an 
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antidepressant, a finding that may offer a partial explanation for the apparently high rates of 
inadequate care among non-physicians. Many persons with long standing depressive 
symptomatology are appropriately treated by intermittent psychotherapy at a frequency of two or 
three visits per year. Thus, our finding that many patients with dysthymia who were treated by 
non-physicians receive inadequate care could be a consequence of how we construct an episode, 
and future research on optimal care for dysthymia may prove valuable. 
Outcome Measures 
 We first examine, ceteris paribus, whether provider choice is related to the likelihood a 
depressed person receives no treatment following initial diagnosis, which is a fundamental form 
of inadequate treatment. We define treatment as the situation where a patient files a claim for any 
antidepressant prescription or any psychotherapy during the year following diagnosis as 
indicated by any claim for an antidepressant or a psychotherapy code. The first of our two 
research questions is then whether, other factors held constant, treatment of a depressed person is 
most likely to occur if the initial contact is with a psychiatrist, psychologist, master’s level 
therapist, or a general medical provider. 
In our second research issue of interest we classify antidepressant therapy, 
psychotherapy, and combination therapy as adequate or inadequate based on the number of 
psychotherapy claims and filled antidepressant prescriptions. Each person treated is then further 
dichotomized into either adequately or inadequately treated. Using guidelines for the treatment 
of major depression established by expert panels of the Agency for Health Care Policy and 
Research (Depression Guideline Panel 1993) and the American Psychiatric Association (APA 
1993), we considered several possible characterizations of treatment adequacy for patients in our 
sample. Expert guidelines generally recommend specific lengths of treatment, which can be 
assessed in claims data such as ours. We considered subjects as receiving adequate care if the 
process of care was consistent with either an adequate course of medication or psychotherapy. 
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The empirical results we present for stage two of our research are based on a low 
threshold level of treatment adequacy. Adherence to medication guidelines means there were 
four or more antidepressant prescriptions filled during the first six months following the index 
date. Our adequacy threshold for antidepressant treatment has been used in previous research and 
shown to be a clinically relevant marker (Melfi et al. 1998; Hylan et al. 1999). 
A minimum of six sessions is generally considered consistent with the experts’ 
recommendations for adequate psychotherapy. Measuring adequate psychotherapy is 
complicated by the recognition that many episodes of major depression may spontaneously 
remit, and a period of so-called watchful waiting may be appropriate. Therefore, as few as two 
follow-up psychotherapy sessions may be appropriate. Here adequate care allows for clinically 
appropriate watchful waiting, and we initially use a minimum of two psychotherapy claims as 
our measure of adequate psychotherapy. We then consider how our conclusions might change if 
adequate anti-depression treatment requires more than two psychotherapy sessions. 
Empirical Results 
The numbers in parentheses in the last column of Table 2 highlight the heterogeneity 
across initial providers in the overall proportion of patients receiving adequate treatment: 88 
percent for psychiatrists, 49 percent for general medical providers, 37 percent for psychologists, 
and 20 percent for master’s level therapists. Table 2 also identifies the substantial heterogeneity 
in treatment initiation across initial providers. The proportion of depressed patients who are 
untreated ranges from about five percent for psychiatrist initial providers to 74 percent for 
master’s level therapist initial providers. Does the wide difference in treatment incidence across 
providers remain after statistical adjustment for patient characteristics? 
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Whether Treatment Occurs 
The specific other factors held constant, or so-called control variables, in our regression 
of whether treatment occurs are measures of the patient’s personal characteristics and health 
status. Personal characteristics in our regressions include age and gender. We capture health 
status by the number of comorbid physical conditions and specific depression diagnosis, such as 
dysthymia where one wants to adjust the estimated effect of provider choice for the possibility 
that low-grade long-term depression often goes untreated. Finally, our model also includes the 
total costs of medical claims in the three months before the depression diagnosis as an indication 
of the patient’s attachment to the health care system. 
The estimated marginal effects in Table 3 relating to initial treatment provider are the 
focus of the first stage of our study of treatment adequacy.5 Particularly noteworthy is that 
diagnosis by a psychiatrist leads to a 41 percentage point increase in the likelihood of being 
treated compared to an initial diagnosis by a general medical practitioner. Diagnosis by what we 
term other mental health specialists significantly reduces the likelihood of treatment. Compared 
to patients diagnosed by general medical practitioners, patients diagnosed by psychologists are 
18 percent less likely to be treated, and patients diagnosed by master’s level therapists are 33 
percent less likely to be treated. Patients initially seen by master’s level therapists are therefore 
74 percentage points more likely to receive inadequate (no) treatment than patients initially seen 
by psychiatrists. 
The ceteris paribus differences in treatment incidence across provider types, as revealed 
by the estimated marginal effects in Table 3, are similar to the differences in average treatment 
incidence of Table 2 because in our data there is little difference in the mixes of patients seen 
across providers. Simple average differences in treatment propensities across provider types do 
not dramatically misrepresent the intrinsic heterogeneity among providers in whether there is any 
treatment at all. As measured by absence of any treatment, general medical practitioners are 
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about seven times more likely to offer no treatment than psychiatrists; master’s level therapists 
and psychologists are about 11 to 15 times more likely to offer no treatment than psychiatrists. 
 Finally, we note that our estimated probit model of interpersonal differences in whether 
treatment is received in Table 3 is informative in an overall sense. A naïve prediction mechanism 
for which patients would receive treatment is to place all persons into the mode, treated, 
situation. The baseline naïve prediction mechanism would then correctly categorize 65 percent of 
patients; our probit model correctly predicts the treatment situation for 80 percent of patients in 
our sample. 
Treatment Adequacy Among Treated Patients 
The list of variables we hold constant in studying how provider type influences treatment 
adequacy among the treated also includes the patient’s age, sex, and number of comorbidities. 
When studying persons treated with depression, we also include more specific information about 
the depression diagnosis. Finally, control variables include several measures of health and the 
propensity to use health care services: pre-diagnosis medical costs; the number of pre-diagnosis 
physician visits, prescriptions, and emergency room visits; as well as an indicator for any prior 
non-psychiatric hospital admission. 
We have noted that for patients overall there is a 30 percentage point difference in the 
dimension of treatment adequacy that is whether treatment is initiated: 65 percent of all 
depressed patients received treatment, and 35 percent did not (Table 2). The first stage of our 
empirical research examined the importance of initial provider and various possible additional 
contributors to individual patient differences underlying the 30 percent point difference along the 
extensive margin of treatment. We now examine the complementary intensive margin of anti-
depression treatment. We are interested in the question of whether, given patient characteristics, 
there are there important differences across providers in the likelihood that a patient’s treatment 
adheres to broad national guidelines for minimally acceptable treatment of depression. Among 
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other issues, is there a benefit to the patient in terms of treatment adequacy from so-called one-
stop shopping in that psychiatrists are the only providers offering both psychotherapy and 
pharmacotherapy? 
Concerning intensity of treatment, the data in Table 2 indicate that 57 percent of all 
patients received adequate treatment, while 87 percent of treated patients received adequate 
treatment. Among patients receiving any treatment, 92 percent who initially saw a psychiatrist 
were treated adequately, while 50 percent who initially saw a general medical practitioner were 
treated adequately. 
Most important for the second stage of our research is that there are much larger 
differences in treatment inadequacy across providers on the extensive margin than across 
providers on the intensive margin. That is, persons initially seeing master’s level therapists are 
15 times more likely to receive no treatment than persons initially seeing psychiatrists; the 
biggest difference in treatment adequacy among the treated is that persons initially seeing 
general medical providers are about half as likely to receive adequate treatment than persons 
initially seeing psychiatrists. We therefore expect to find smaller ceteris paribus differences in 
treatment inadequacy across the initial providers of treated patients than the difference we found 
across the initial providers concerning the inadequacy measure of whether any treatment at all 
occurred. 
Table 4 presents the second (treatment adequacy) equation in our bivariate probit model 
of the dual outcome of whether any treatment occurred and adequacy of treatment conditional on 
treatment occurring.6 The main result to emerge concerning treatment adequacy among the 
treated is that there is a sharp distinction in our findings for treatment inadequacy via treatment 
intensity versus our finding for lack of any treatment. Holding constant patient demographics, 
type and severity of depression, and pre-depression episode health and medical care use, there 
are fewer and less significant differences in treatment adequacy among treated patients across 
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initial provider types. Compared to the base group of general medical practitioners, treatment 
adequacy is 4 to 5 percentage points greater for patients seeing psychologists and 14 to 15 
percentage points greater for persons seeing psychiatrists. Unlike whether treatment occurs at all, 
where there can be a 70 percentage point difference across providers, when patient 
characteristics are held constant the largest difference in treatment adequacy is 10 percentage 
points. In both dimensions of treatment adequacy, treatment initiation and treatment adequacy 
among the treated, psychiatrists have the largest positive ceteris paribus impact on their patients. 
An implication of sample selection bias if one were to study treatment adequacy in 
isolation is that there are latent factors common to the outcomes of whether any treatment is 
begun and whether treatment is adequate among patients who are treated. Because the estimated 
correlation between the error terms of the two probit equations in our bivariate probit model is 
insignificantly different from zero, the results in Table 4 do not indicate a latent common factor 
that might underlie a problematic sample, one determined by the outcome to be explained. In our 
data there seems to be no evidence of a feedback effect from likely treatment adequacy and the 
decision to begin treatment. 
Robustness Check: Adequacy Measure and Depression Type 
It is important to examine whether our focal result, that patients who initially see 
psychiatrists are more likely to be treated and for that treatment to be adequate, still holds if we 
consider two basic data issues concerning outcome measure and sample composition. To check 
the robustness of our conclusions thus far, we re-estimated our bivariate probit model first using 
a more stringent definition of adequacy on the psychotherapy dimension and then using only the 
sub-sample of persons with major depression. 
As our first basic robustness check, we re-ran the bivariate probit model of Table 4 using 
a stricter definition of adequacy: at least four (rather than two) psychotherapy visits for treatment 
to be termed adequate. The possible latent common factor influencing both the likelihood of 
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treatment and treatment adequacy among the treated (the selection bias effect) was again 
statistically insignificant (P = 0.67), and the marginal effect of psychiatrist on the likelihood of 
treatment adequacy was again positive and statistically significant, although a third smaller when 
we doubled the number of psychotherapy visits in our treatment adequacy threshold (ME = 
0.102, P = 0.004). 
In our second basic robustness check we re-estimated the models in Tables 3 and 4 on the 
sub-sample of 1,114 persons being treated for serious depression only. The coefficient of a 
psychiatrist initial provider was again positive and significant in the simple probit for adequate 
treatment with a 50 percent smaller marginal effect on the likelihood that any treatment occurs 
(ME = 0.22, P = 0.000). The difference between the effect of psychiatrist versus other providers 
on treatment adequacy among the treated also shrinks (by 33 percent) when we consider only 
patients with major depression compared to all depression types in Table 4 (ME = 0.104, P = 
0.007). 
In summary, when we consider a more restrictive definition of adequacy or a more 
restrictive estimation sample including only patients with major depression, having a psychiatrist 
as the initial provider maintains its positive differential over the other types of providers. Taken 
in conjunction with the results of Tables 3 and 4, a patient initially seeing a psychiatrist is as 
much as four times more likely to receive treatment and a treated patient 1.25 times more likely 
to receive adequate treatment. Our core result continues to hold, which is that patients initially 
seeing a psychiatrist are more likely to receive treatment and for that treatment to be adequate 
with the differential effect of a psychiatrist initial provider much larger on the extensive than 
intensive margin of treatment. 
Robustness Check: Endogenous Provider Choice 
 As the final segment of our empirical examination of the link between provider type and 
course of depression treatment, we consider more fully the issue that the type of initial provider 
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is obviously not randomly assigned in our observational data. We again focus our robustness 
checking on the coefficient of psychiatrist. We elaborate, conceptually and empirically with 
additional regression results, on two situations: (1) initial provider type depends on observable 
patient characteristics, and (2) initial provider type depends on a latent common factor that 
reflects the propensity of the patient to seek treatment from a psychiatrist and to participate in an 
adequate treatment regimen. 
 The regressions in Tables 3 and 4 adjust for one type of non-randomly determined 
(endogeneity of) provider type whereby the mental health provider is determined by and 
therefore correlated with observable patient characteristics. To ignore any connection between 
the characteristics of the patients and the provider type regressor would lead the researcher to 
attribute to provider the dual effects of the patient’s characteristics on whom he or she sees 
initially and the additional effects of the patient’s characteristics on treatment adequacy and 
intensity. We avoid some obvious omitted variable biases in the estimated effects of provider 
types on treatment incidence and adequacy by including as control regressors measured aspects 
of the patients’ demographic characteristics, health, and type of depression. The results in Tables 
3 and 4 are purged of the most basic type of non-randomization of initial provider, which is that 
the patient’s demographic characteristics, health, and depression type are not unrelated to the 
provider type. 
 There is another, more statistically subtle, type of endogeneity that is not necessarily 
purged in the results of Table 4, which is that there may also be a latent common factor between 
provider type (specifically, whether one initially sees a psychiatrist) and treatment incidence and 
intensity that makes a person more likely to want to see a psychiatrist and submit to the treatment 
regime a psychiatrist typically offers. Such a latent common factor, if present but un-modeled 
would make the results of Table 4 overstate the positive differential impact of a psychiatrist on 
treatment outcomes. 
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 The most obvious way to deal with the issue of a latent common factor here is again 
through a multivariate probit model (Greene 2003). We were unsuccessful at estimating a 
trivariate probit model of provider type, treatment, and treatment adequacy among the treated 
(the likelihood function would not converge). As a second best solution we estimated two 
additional bivariate probit models that focus on the possible differential impact of a psychiatrist: 
(1) a bivariate probit model of whether psychiatrist was the initial provider and then whether the 
patient got any treatment and (2) a bivariate probit model of whether psychiatrist was the initial 
provider and then whether the patient who received any treatment got adequate treatment. 
Together, the two additional bivariate probit models further purify our conclusions for possible 
endogeneity of provider type, while continuing to address possible selection bias in that only 
treated patients are in the sample for the portion of the model examining treatment adequacy.7 
 In the bivariate probit model for whether the psychiatrist was the initial provider and 
whether the patient was in turn treated, the estimated latent common factor is negative and 
statistically insignificant ( ˆ 0.121ρ = − , P = 0.23). Persons who, for reasons not related to their 
observed characteristics, are more likely to seek treatment from a psychiatrist are not also more 
likely to submit to treatment. In the bivariate probit model that includes a latent common factor 
between having a psychiatrist as an initial provider and treatment adequacy, the estimated latent 
common factor is also negative and statistically insignificant at conventional levels ( ˆ 0.146ρ = − , 
P = 0.10). Persons who, for reasons unrelated to the observed characteristics, are more likely to 
seek treatment from a psychiatrist are not also more likely to submit to more intense (adequate) 
treatment.  
 The message from the results of our two additional bivariate probit models is 
straightforward. There is a positive and notable differential effect of a psychiatrist initial provider 
that is not altered by the type of possible (latent common factor) endogeneity that is un-modeled 
in Tables 3 and 4.8 
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Discussion 
Even after adjusting for patient mix, the disparities among provider types in whether any 
treatment occurs are much larger than the disparities across providers in whether treatment 
initiated is adequate. A stark result emerging is that depressed persons initially diagnosed by 
non-physician mental health specialists are far less likely to be treated at all for depression than 
persons diagnosed by medical providers, whether psychiatric or general practitioners. Most 
noteworthy in our data is that 75 percent of untreated depressed patients had dysthymia, and 72 
percent of the untreated suffering from dysthymia initially saw a master’s level therapist. What 
are possible reasons for the much higher incidence of non-treatment of depressed patients 
initially seen by non-medical providers? 
Premature termination from the treatment of mental disorders, including the specialized 
case of immediate dropout after a single visit, is a long-standing problem for the mental health 
system. In a comprehensive review, Baekeland and Lundwall (1975) identify at least 15 distinct 
variables that predict dropout, including patient social isolation, denial, passive-aggressiveness, 
family attitudes and behavior, therapist attitudes, and discrepancies in expectations between the 
patient and therapist. Indeed, multiple factors often contribute at the level of an individual 
patient. We contribute to the literature following recent advances in pharmacotherapy and brief 
psychotherapy techniques by highlighting the magnitude of the emerging distinction between 
various providers of treatment. 
Differences in dropouts in our data complicates our statistical analysis by introducing the 
possibility of selection bias. For example, one possible scenario underlying our main result is 
that persons who initially seek treatment from master’s level therapists or psychologists have an 
underlying latent (to the researcher) predisposition not to follow through with treatment 
subsequently. The predisposed patient we have in mind is drawn to a non-medical provider in 
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order to find out about treatment but then decides against it or seeks follow-up care through self-
help groups or pastoral counseling (Swindle et al. 2000). Another possibility for the relatively 
high incidence of treatment among medical providers is data construction. Physicians may code 
depression as the visit reason only for patients they believe likely to follow through with 
treatment, at least in the period immediately following the physician’s diagnosis (Rost et al. 
1994). A third possibility is that there are relevant unmeasured differences in the severity of 
depression across patients, which make patients less in need of continued care seek out 
psychologists and master’s level therapists. It follows directly that there is a need to use 
multivariate techniques to mitigate selection effects. 
Although the data we use are from the early 1990s, we believe our results could have 
important implications for how mental health care is delivered currently. Specifically, the 
associations between provider type and treatment provision are consistent with recent findings 
that depression frequently remains unrecognized (Hirschfeld et al. 1997) and is poorly treated 
when recognized (Young et al. 2001). The typical quality of care for depression has changed 
little even though the number of people who receive mental health benefits through carved-out 
managed behavioral health care has increased rapidly (Findlay 1999). Provider networks 
established by managed care are heavily reliant on non-physician mental health specialists 
(Goldman 2001). Our regression estimates may suggest a reason for continued low-quality 
treatment, even as access to mental health treatments, both psychosocial and pharmaceutical, 
have expanded. Much of the new care depends on the initial evaluation by non-physician 
specialists, but little follow-up care is being provided. 
We offer an explanation for the observation that many who receive care from non-
physicians have only a single visit with no subsequent care. Most Americans (Swindle et al. 
2000) and most depressed patients (Dwight-Johnson et al. 2000) express preferences for talk 
therapy over medication treatment, so that patients simply may not understand the nature of talk 
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therapy or the wide variation in the nature of psychosocial treatments that are offered. Poorly 
understood wide variation in psychosocial treatments may act as an impediment to seeking 
further care for the large proportion of patients who apparently prefer psychotherapy.  
 The stark result presented here is that non-treatment is an extreme form of inadequate 
treatment that varies systematically with initial provider type, ceteris paribus. Untreated 
depression is an important issue because there are notable consequences, including unneeded 
reductions in well-being and lengthening of time depressed (Berndt et al. 1998, 2000; Sacket and 
Torrence 1978; Anton and Revicki 1995; Murray and Lopez 1996; and Fryback et al. 1993). The 
main policy implication of our research is that clearer understanding of how the health care 
system might better serve depressed persons may require researchers to focus on the link 
between initial provider and non-initiation of treatment. A logical first step is to understand why 
so many apparently depressed persons receive no further treatment following the diagnosis, 
which would allow more focused programs that improve access and quality of care for a 
devastating illness. 
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1. We discuss the role of insurance on provider choice below in the Data section under 
Empirical Framework. 
 
2. Later we consider the possibility that the type of provider the patient sees initially may be 
based on the provider’s likely amount of treatment. 
 
3. An additional advantage of the bivariate probit is that X1 and X2 need not differ because 
of the non-linearity of the model. Conceptually, the same things will affect both margins 
of treatment. Rather than arbitrarily eliminate variables from X1 and X2, we present 
results for the case where X1 ≡ X2. Robustness checks for versions of the model with X1 
≠ X2 left the coefficients of interest unchanged in terms of general magnitudes and 
statistical significance. 
 
4. We ignore so-called brief and prolonged depressive reaction disorders because they are a 
response to an identifiable stressor and typically not treated with either medication or 
counseling. 
 
5. We did not pursue binary outcome regression models that are not based on the 
assumption of a particular error distribution, such as the normal that we use, the logistic 
that is the basis of the logit, or the uniform that is the basis of the linear probability 
model. The most popular of the so-called semi-parametric binary outcome models is the 
maximum score, or M-Score, estimator. By construction the M-Score will give the best 
in-sample fit. However, the M-Score and other semi-parametric estimators do not reveal 
marginal effects of the independent variables, which are the focus of our research 
(Greene 2003). 
 
6. For the reasons mentioned above and tractability we also did not pursue estimating a 
semi-parametric bivariate outcomes model. 
 
7. To allow the additional bivariate probit models to have maximal chance to locate a 
significant latent common factor, we estimated them without identical regressor lists in 
the two equations. The regressor lists for each equation were selected by running single 
equation probit regressions and using the variables in the bivariate models that had P ≤ 
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ˆ
0.10 in the three simple probit models for initial provider is a psychiatrist, treatment, and 
adequate treatment. 
 
8. If we were to ignore the lack of statistical significance of ρ  in our ancillary bivariate 
probits, the calculated differential impact of a psychiatrist is larger because a negative 
value of ρ̂  means that persons who, for reasons unknown to the researcher, are more 
likely to see a psychiatrist are also less likely to be treated or to receive adequate 
treatment. Controlling for psychiatrists’ patients’ possible latent propensities not to be 
treated or not to be treated adequately enlarges the estimated differential effect of having 
a psychiatrist as an initial provider on treatment incidence and adequacy. 
 
Table 1. Sample Summary Statistics 
(N =5,562) 
Variable Mean 
Standard 
Deviation 
Demographics   
Age 40.913 10.138 
Proportion female 0.737 0.440 
   
Type of Depression (proportions)   
Major depression, single episode 0.113 0.316 
Major depression, recurrent 0.089 0.285 
Dysthymia 0.667 0.471 
Depression not otherwise specified 0.133 0.340 
   
Health   
Number of comorbid medical conditions 4.712 2.800 
Number of anxiolytic scripts 0.168 0.791 
Pre-period medical costs ($) 
Pre-period non-psychiatric hospital admission (proportion) 
Number psychotherapy visits 
Number of pre-period ER visits 
Number of pre-period physician visits 
Number of pre-period scripts 
561.907 
0.025 
8.003 
0.099 
2.945 
2.997 
2548.590 
0.155 
13.207 
0.448 
5.603 
5.403 
   
Initial Mental Health Provider (proportions)   
Psychiatrist 0.439 0.496 
Primary care  0.216 0.412 
Mental health specialist 0.345 0.475 
Psychologist 
Master’s level therapist 
0.058 
0.286 
0.235 
0.452 
   
Treatments and Adequacy (proportions)   
No treatment 0.346 0.476 
Medication only  0.096 0.294 
Psychotherapy only  0.354 0.478 
Combination treatment 0.204 0.403 
Treatment met adequacy guidelines 0.570 0.495 
Source: Authors’ calculations. 
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Table 2. Guideline Adherence by Provider and Treatment Type 
 No Tx Medication Psychotherapy 
Combined 
Tx Total 
Psychiatrist 128 
5% 
(0%) 
37 
2% 
(70%) 
1485 
61% 
(90%) 
792 
32% 
(98%) 
2442 
100% 
(88%) 
Psychologist 185 
57% 
(0%) 
25 
8% 
(68%) 
84 
26% 
(89%) 
31 
10% 
(94%) 
325 
100% 
(37%) 
MA Therapist 1186 
74% 
(0%) 
134 
8% 
(69%) 
170 
11% 
(81%) 
102 
(6%) 
(94%) 
1592 
100% 
(20%) 
Primary Care 427 
35% 
(0%) 
337 
28% 
(63%) 
231 
19% 
(76%) 
208 
17% 
(96%) 
1203 
100% 
(49%) 
Total 
1926 
(0%) 
533 
(65%) 
1970 
(88%) 
1133 
(97%) 
5562 
(57%) 
*Numbers in parentheses are percent of cell adequately treated. 
Source: Authors’ calculations 
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Table 3. Probability of Treatment: Single Equation Maximum Likelihood 
Probit Results (n=5,562) Predictive Power: 80 Percent Accuracy 
Variable Coefficient 
Standard 
Error P-value 
Marginal 
Effect 
Constant 0.248 0.112 0.027 0.082 
     
Mental Health Providers     
Psychiatrist 1.241 0.637 0.000 0.411 
Psychologist −0.556 0.085 0.000 −0.184 
Master’s level therapist −1.009 0.589 0.000 −0.333 
     
Demographics     
Age/10 −0.009 0.021 0.638 −0.003 
Female 0.077 0.049 0.114 0.026 
     
Health   
Number of comorbid medical 
conditions 
0.019 0.008 0.017 0.006 
Number of anxiolytic scripts 0.079 0.031 0.009 0.026 
Pre-period medical costs/1000 −0.005 0.008 0.585 −0.002 
Pre-period physician visits −0.013 0.004 0.002 −0.004 
Pre-period scripts −0.004 0.004 0.346 −0.001 
Pre-period ER visits 0.031 0.045 0.484 0.010 
Pre-period non-psychiatric 
hospital admission 
−0.030 0.149 0. 841 −0.010 
     
Types of depression     
Major single depression 0.274 0.084 0.001 0.091 
Major recurrent episode 0.556 0.103 0.000 0.184 
Dysthymia −0.018 0.065 0.782 −0.006 
  
Note: Primary care physicians are the reference provider category. 
Source: Authors’ calculations. 
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Table 4. Probability of Adequate Treatment, Given Any Treatment Selection 
Bias Corrected Bivariate Probit Results 
Variable Coefficient 
Standard 
Error P-value 
Marginal 
Effect 
Constant 0.346 0.473 0.464 0.065 
     
Mental Health Providers     
Psychiatrist 0.767 0.307 0.012 0.14465 
Psychologist 0.241 0.299 0.420 0.045 
Master’s level therapist −0.081 0.467 0.863 −0.015 
     
Demographics     
Age/10 0.048 0.027 0.078 0.009 
Female 0.065 0.069 0.344 0.012 
     
Health     
Number of comorbid medical 
conditions 
−0.006 0.012 0.622 −0.001 
Number of anxiolytic scripts 0.137 0.056 0.014 0.026 
Pre-period medical costs/1000 −0.002 0.015 0.880 −0.000 
Pre-period physician visits −0.018 0.006 0.002 −0.003 
Pre-period scripts −0.007 0.006 0.200 −0.001 
Pre-period ER visits −0.007 0.050 0.882 −0.001 
Pre-period non-psychiatric 
hospital admission 
−0.109 0.183 0.533 −0.020 
     
Types of depression     
Major single depression 0.087 0.124 0.480 0.016 
Major recurrent episode 0.119 0.178 0.505 0.022 
Dysthymia 0.166 0.083 0.045 0.031 
     
Note: Adequacy of treatment equation based on 3,636 treated individuals. The estimated coefficient of 
correlation between the error terms of the first-stage probit explaining the existence of treatment and the 
second-step probit above explaining treatment adequacy among the treated (ρ) is 0.205 with a standard 
error of 0.641 and associated P-value of 0.749. Model estimate of probability of guideline adherence, 
given treatment, is 86.4 percent. 
Source: Authors’ calculations.  
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